Fouad Namouni Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Fouad Namouni is PRESIDENT, R & D of Blueprint Medicines Corp. Currently has a direct ownership of 69,070 shares of BPMC, which is worth approximately $6.25 Million. The most recent transaction as insider was on Oct 03, 2024, when has been sold 3,633 shares (Common Stock) at a price of $89.32 per share, resulting in proceeds of $324,499. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.1K
5.0% 3M change
11.26% 12M change
Total Value Held $6.25 Million

Fouad Namouni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2024
SELL
Open market or private sale
$324,499 $89.32 p/Share
3,633 Reduced 5.0%
69,070 Common Stock
Mar 07 2024
SELL
Open market or private sale
$396,950 $90.69 p/Share
4,377 Reduced 5.68%
72,703 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 16.29%
77,080 Common Stock
Oct 04 2023
SELL
Open market or private sale
$181,138 $48.06 p/Share
3,769 Reduced 5.72%
62,080 Common Stock
Mar 06 2023
SELL
Open market or private sale
$87,737 $45.04 p/Share
1,948 Reduced 2.87%
65,849 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
15,000 Added 18.12%
67,797 Common Stock
Oct 04 2022
SELL
Open market or private sale
$234,002 $67.3 p/Share
3,477 Reduced 6.18%
52,797 Common Stock
Mar 07 2022
SELL
Open market or private sale
$58,831 $56.19 p/Share
1,047 Reduced 1.83%
56,274 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 20.74%
57,321 Common Stock
Oct 05 2021
SELL
Open market or private sale
$318,201 $98.18 p/Share
3,241 Reduced 7.11%
42,321 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
13,062 Added 22.28%
45,562 Common Stock
Oct 01 2020
BUY
Grant, award, or other acquisition
-
32,500 Added 50.0%
32,500 Common Stock

Also insider at

APRE
Aprea Therapeutics, Inc. Healthcare
Director
VOR
Vor Biopharma Inc. Healthcare
FN

Fouad Namouni

PRESIDENT, R & D
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC